Skip to main content

DiMe Publications

With Covid-19 halting clinical trials, wearables could be key — but data ‘wild west’ gets in the way

Jordan Bryanov and DiMe leaders Jen Goldsack and Bill Byrom advocate for the biotech, pharma, and tech sectors to work together and leverage their collective purchasing power to drive the adoption of common standards to scale the use of digital clinical measures in clinical research.

August 2020 in STAT News

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today